‘Not having data exclusivity is a boon for biosimilar or biobetter prospecting in…
Dr Gopakumar G Nair, Founder, Gopakumar Nair Associates speaks with Usha Sharma and predicts that data exclusivity and other…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
BioPh India
’Biobetter drugs principal foundation of science to provide cost effective drugs’
Association of Biotechnology Led Enterprises (ABLE) has formulated a robust biosimilars policy for India and is considering the…
‘Indian players are increasingly eyeing to capitalise on the opportunities in biobetters…
Indian biosimilar sector has picked up momentum in the past few years. Shakthi M Nagappan, Executive Secretary – FABA, CEO,…
Seward introduces searchable online database for sample preparation protocols
Seward, manufacturer of the world leading range of Stomacher paddle blenders and Stomacher accessories used in sample preparation…